FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> Merck   HPV   Gardasil
Syndicate content

FDA rejection News

Most Popular FDA rejection Story

FDA rejects Merck's Gardasil for women over 26

The FDA has rejected Merck's ($MRK) request to market its HPV vaccine Gardasil to women between the ages of 27 and 45. The company had hoped the expanded use could boost slumping sales, which dropped Read more...

FDA rejection Press Releases

  • FDA Declines to Approve Santarus Inc. (SNTS)'s OTC Heartburn Drug
  • Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome
  • PRESS RELEASE: Indevus Receives Non-Approvable Letter From FDA for VALSTAR

Latest Headlines